发明名称 An antibody specific for soluble BAFF for use in the treatment of cancer
摘要 <p>Stimulating B-cell growth, immunoglobulin production, or dendritic cell-induced B-cell growth and maturation, or co-stimulating B-cell growth and immunoglobulin production, comprising administering a composition containing the tumor necrosis factor family B cell activating factor (BAFF) or its active fragment, and optionally an anti-Micro antibody, a CD40 ligand or an anti-CD40 ligand, is new. An independent claim is also included for a method of inhibiting B-cell growth, immunoglobulin production, or dendritic cell-induced B-cell growth, or co-inhibiting B-cell growth and immunoglobulin production, comprising administering an anti-BAFF ligand molecule, a recombinant, inoperative BAFF ligand molecule, an antibody specific for BAFF ligand, active fragments of the molecules, or an antibody specific for BAFF ligand receptor, or an epitope of it. ACTIVITY : Immunosuppressive; virucide; antiinflammatory; hypotensive; nephrotropic; cardiant; cytostatic. No biological data is given. MECHANISM OF ACTION : B-cell growth and/or immunoglobulin production stimulators or inhibitors.</p>
申请公布号 EP1415659(B1) 申请公布日期 2011.07.06
申请号 EP20030018879 申请日期 2000.01.25
申请人 BIOGEN IDEC MA INC.;APOXIS SA 发明人 BROWNING, JEFFREY;AMBROSE, CHRISTINE;MACKAY, FABIENNE;TSCHOPP, JURG;SCHNEIDER, PASCAL
分类号 A61K38/17;C12N15/09;A01K67/027;A61K31/44;A61K38/00;A61K38/19;A61K39/395;A61K45/00;A61K48/00;A61P7/00;A61P9/00;A61P9/12;A61P13/12;A61P29/00;A61P31/18;A61P35/00;A61P37/02;A61P37/04;A61P37/06;A61P43/00;C07C233/44;C07C271/22;C07D213/73;C07D401/04;C07D405/12;C07K14/705;C07K16/28;C12N15/85 主分类号 A61K38/17
代理机构 代理人
主权项
地址
您可能感兴趣的专利